Enhanced green ‰uorescent protein (EGFP) was fused with staphylococcal protein A (SpA) and used as a substrate for proteases. An SpA-EGFP assay was done in three steps: (i) digestion of SpA-EGFP by proteases, (ii) addition of rabbit IgG immobilized on Sepharose beads, and (iii) measurement of the ‰uorescence intensity of supernatant. The assay was sensitive enough to measure picogram levels of trypsin and chymotrypsin, and may be applicable to various other proteases as one of the most sensitive methods.
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Assays for low levels of protease activity are important for not only basic research on proteases but also the quality control of many buŠer solutions. In protein puriˆcation, one of the most serious threats to protein stability is the omnipresent proteases. A general precaution to prevent proteolytic degradation is to use high-quality buŠers with added protease inhibitors. Although the kinds and concentrations of inhibitors diŠer slightly for each case, buŠers are judged to be working well by the detection of low levels of remaining protease activity. Currently, several sensitive assays have been developed using Coomassie brilliant blue G-250, 1, 2) ‰uorescence polarization, 3, 4) ‰uorescein isothiocyanate (FITC)-labeled substrate, 5, 6) or intramolecularly quenched substrate. 7, 8) In this report we present a new type of simple and highly sensitive assay using green ‰uores-cent protein (GFP).
GFP from Aequorea victoria is now widely used in cell biology as a marker for gene expression and a fusion tag in studying protein localization and secretion systems in living cells. [9] [10] [11] As a new application of GFP outside of cells, we previously reported the construction of a fusion protein with GFP and staphylococcal protein A (SpA) and its use in Western blotting. [12] [13] [14] In this study, GFP was replaced with enhanced GFP (EGFP) to raise the ‰uorescent intensity, and a highly sensitive assay for proteases was devised using SpA-EGFP fusion protein and rabbit IgG immobilized on Sepharose beads.
Puriˆcation and characterization of SpA-EGFP. The EGFP-coding region was ampliˆed by standard PCR using pEGFP-N1 (Clontech Laboratories, Inc., Palo Alto, CA) as a template. The primers used were as follows: 5?-TTTGAATTCATGGTGAGCAAG-GGCGAGGAGCTG-3? and 5?-CCCAAGCTTCT-ATTACTTGTACAGCTCGTCCAT-3? ( EcoRI and HindIII sites are underlined). The fragment was digested with EcoRI and HindIII, then cloned into the E. coli expression vector pKK223-3 (Pharmacia Biotech, Uppsala, Sweden). The resulting plasmid was designated pKKEGFP. The EcoRI fragment encoding staphylococcal protein A, which was prepared from pPAGFP147P, 14) was cloned into the EcoRI site of pKKEGFP, and the resulting plasmid was designated pPAEGFP (Fig. 1a) .
E. coli JM109 harboring pPAEGFP was grown in 200 ml of LB broth until the midlog phase at 379 C. After adding 0.6 ml of 100 mM isopropyl-b-D-thiogalactopyranoside (IPTG; Wako Pure Chemical Industries, Ltd., Osaka, Japan), the cells were grown at 259 C for 18 h and harvested by centrifugation. Cells were suspended in 20 ml of 10 mM Tris-HCl buŠer (pH 8.0) containing 10 mM EDTA and 30 mM NaCl (TEN buŠer), and disrupted by sonic oscillation. The supernatant obtained by centrifugation was placed on a column (2.5×4 cm) containing rabbit IgG immobilized on Sepharose 6B (Pharmacia Biotech) and the bound materials were eluted with TEN buŠer containing 9 M urea. Fractions emitting green ‰uorescence under UV light at 365 nm (CSL-6A, Cosmo Bio Co., Ltd., Tokyo, Japan) were pooled and dialyzed against 10 mM Na-phosphate (a) EGFP was fused with a part of SpA containing three IgG binding domains and expressed in E. coli. The SpA segment and several amino acids of the N-and C-terminals in EGFP are digested by proteases. Therefore, the IgG binding activity is eliminated by protease digestion but the ‰uorescence of EGFP is not aŠected. (b) Portions (100 ml) of SpA-EGFP solutions (0.625-40 mg W ml) were poured into the wells of a 96 well microplate and the ‰uorescence was measured with a ‰uorescence microplate reader (Spectra Fluor Plus, Tecan Japan Co. Ltd., Tokyo, Japan) using 485 nm excitation and 535 nm emissionˆlters.
buŠer (pH 7.0). From 200 ml of culture, 6.3 mg of puriˆed SpA-EGFP was obtained. Puriˆed SpA-EGFP had strong ‰uorescence activity, and its intensity was linear over a wide range of concentrations (Fig. 1b) . No decrease in ‰uorescence or IgG binding activity was observed at "209 C for several months. Moreover, these activities were not aŠected by repeated freezing and thawing.
The SpA-EGFP assay was done as follows: (i) digestion of SpA-EGFP by proteases in a microtube, (ii) addition of rabbit IgG immobilized on Sepharose beads, and (iii) measurement of ‰uorescence intensity of the supernatant. SpA-EGFP is a metabolically labeled IgG binding protein. As shown in Fig. 1a , the SpA segment contains three IgG binding domains. This assay is based on not only the IgG binding activity of the SpA segment but also the strong and stable ‰uorescence of EGFP. This stability appears to be the consequence of its unique three dimensional structure named the``b-can''. 15) Many proteases (trypsin, chymotrypsin, thermolysin, papain, subtilisin, and pancreatin) have been shown to have no eŠect on Aequorea GFP ‰uorescence at a concentration of 1 mg W ml. 16) EGFP, an Aequorea GFP variant having the amino acid substitutions of F64L and S65T, was also extremely stable to protease digestion. Even after 24 h of incubation, trypsin or chymotrypsin (1 mg W ml) did not aŠect EGFP ‰uores-cence. In contrast to EGFP, the SpA segment was normally digested by many proteases, and lost the IgG binding activity.
SpA-EGFP assay for trypsin and chymotrypsin solutions. Using SpA-EGFP and a commercialized intramolecularly quenched substrate, BODIPY FL-labeled casein, 7) a wide range of trypsin and (a) In the SpA-EGFP assay, 100 ml portions of trypsin or chymotrypsin solutions (1 pg W ml"1 mg W ml) were mixed with SpA-EGFP and incubated for 1 h at 309 C. After addition of rabbit IgG immobilized on Sepharose beads, the ‰uorescence of the supernatant was measured using a ‰uorescence microplate reader (Spectra Fluor Plus, ex＝485 nm and em＝535 nm). In the BODIPY assay, 100 ml of each protease solution was mixed with the working solution and incubated for 1 h at 309 C. The ‰uorescence was measured using the same ‰uorescence microplate reader. See text for details. (b) The SpA-EGFP assay for trypsin was continued for a long time. After incubation for 3 h and 24 h, the ‰uorescence was measured. chymotrypsin solutions were assayed. A series of trypsin (4923 USP trypsin units W mg, Wako Pure Chemical Industries) or chymotrypsin (60 units W mg, Worthington Biochemical Corp., Freehold, NJ) solutions (0.1 pg W ml"1 mg W ml) were prepared with TBS; 50 mM Tris-HCl, 200 mM NaCl, pH 7.4. Each protease solution (100 ml) was mixed with 90 ml of TBS and 10 ml of puriˆed SpA-EGFP (0.35 mg W ml) and incubated at 309 C in a microtube. After incubation for 1 h, 150 ml of gel suspension containing about 100 ml of rabbit IgG-immobilizing Sepharose 6B gel was added and gently mixed for 5 min at room temperature. The mixture was centrifuged at 9500 g for 30 sec and the ‰uorescence intensity of the supernatant (150 ml) was measured with a ‰uorescence microplate reader using standard ‰uoresceinˆlters (ex＝485 nm and em＝535 nm). Under these assay conditions, the remaining ‰uorescence of the supernatant in the no protease control was lower than 1z of total ‰uores-cence.
An intramolecularly quenched substrate assay was done with an EnzCheck Protease Assay Kit E-6638 (Molecular Probes, Inc., Eugene, OR) according to the manufacturer's instructions. A series of trypsin or chymotrypsin solutions were prepared with 1X digestion buŠer (10 mM Tris-HCl, pH 7.8). Each protease solution (100 ml) was mixed with 100 ml of the working solution containing BODIPY FL-labeled casein. After incubation for 1 h at 309 C, the ‰uores-cence was measured with the same ‰uorescence microplate reader using standard ‰uoresceinˆlters.
As shown in Fig. 2a , the assay range of SpA-EGFP was around 10 "7 "10 "11 g after incubation for 1 h. The SpA-EGFP assay was su‹cient to measure picogram-levels of protease, and the sensitivity was superior to that of the BODIPY assay by about 100-fold. Since the ‰uorescence intensity changes over a wider range than in the BODIPY assay, the SpA-EGFP assay can detect subtle protease changes. The longer incubation assay range of SpA-EGFP was around 10 "8 "10 "11 g for 3 h and 10 "9 "10 "12 g for 24 h (Fig. 2b) . The assay, of course, could be used for monitoring the eŠect of protease inhibitors. A precise measurement of its eŠect is important for the choice of inhibitors and working concentration. As a typical serine protease inhibitor, phenylmethylsulfonyl ‰uoride (PMSF) was examined. As shown in Fig. 3 , PMSF inhibited trypsin and chymotrypsin activities depending on its concentration, but the inhibitory eŠect of PMSF on the proteases was clearly diŠerent.
The SpA-EGFP assay has the following useful properties: (i) no special chemicals, including a ‰uorescence-labeled substrate, are required, (ii) the procedure is simple, and the sensitivity is su‹cient to analyze picogram-level samples, and (iii) the ‰uores-cence of EGFP is extremely stable for long periods of storage and repeated freezing and thawing, and therefore, the handling is very easy. Since GFP loses ‰uorescence under acidic conditions, the SpA-EGFP assay is not suitable for acidic proteases such as pepsin. However, this assay may be useful for various other proteases as one of the most sensitive methods available. The inhibitory eŠect of PMSF was examined by SpA-EGFP assay. Twenty microliters of PMSF solution (10 "2 "10 "7 M) was mixed with 10 ml of puriˆed SpA-EGFP (0.35 mg W ml) and 170 ml of 0.1 mg W ml trypsin () or chymotrypsin () solution. After 1 h of incubation at 309 C, the ‰uorescence of the supernatant was measured as described. The ‰uorescence obtained from the no-PMSF control was taken as 100z.
